← Back to home

LifeCare Medical CenterNon-Profit

EIN: 411804205

UEI: V9MUYSYZ7MH3

Audited by: Eide Bailly LLP

Oversight agency: 93 [Department of Health and Human Services]

View federal awards & risk assessment →

Data as of September 2, 2026

LifeCare Medical Center2 audit years4 findings
2
Audit Years
4
Total Findings
0
Repeat Findings
$1.7M
Federal Awards Expended (FY 2023)

FY 2023-09-30

$1,749,015 federal awards expended

Management decision deadline — for entities that funded this organization

The FAC accepted this audit on June 24, 2024. Under 2 CFR 200.521(d), a pass-through entity that provided federal funds to this organization for this audit period must issue a management decision on these findings by December 24, 2024 (620 days ago).

What is a management decision? →
2023-002
Reporting
MATERIAL WEAKNESSMODIFIED OPINION

2023‐002 Department of Health and Human Services Federal Assistance Listing #93.498 COVID‐19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Applicable Federal Award Number and Year – Period 4 TIN #411804205 Reporting Material Weakness in Internal Control over Compliance and Material Noncompliance Criteria ‐ 2 CFR 200.33(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statues, regulations, and conditions of the federal award. The Medical Center is required to submit an accurate report to HHS for the filing period that funds were received. Condition ‐ The Medical Center claimed lost revenues attributable to coronavirus in which the revenue calculation did not agree to the HHS special report for one key line item. Cause ‐ The Medical Center had a revenue calculation error of $192,326 on the HHS special report with no impact to the actual lost revenues as the quarter with the error did not result in any lost revenue being reported (i.e., lost revenue claimed was accurate on the HHS special report but key line items were misstated). Effect ‐ While the calculation error did not provide a difference in total between the lost revenues utilized on the HHS special report and the lost revenue calculation, the Medical Center’s reported quarterly resident revenues were inaccurate. This calculation error also indicated a lack of proper reconciliation between the Medical Center’s audited financial statements and the revenues reported within the HHS special report. Questioned Costs ‐ None reported. Context ‐ There were 40 lost revenue key line items tested on which one key line item contained an error which totaled $192,326 (explicit price concessions were overstated for one quarter). The error had no impact on the amount of lost revenue as the quarter impacted did not result in any lost revenue. Repeat Finding from Prior Years – No Recommendation ‐ We recommend that the Medical Center enhance internal control policies to ensure the HHS special report is supported by accurate revenue calculations. This would include reconciling the lost revenue calculation to the audited financial statements within the secondary review of the HHS special report. Views of Responsible Officials ‐ Management agrees with the finding.

Show full finding ▾
Full finding narrative

2023‐002 Department of Health and Human Services Federal Assistance Listing #93.498 COVID‐19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Applicable Federal Award Number and Year – Period 4 TIN #411804205 Reporting Material Weakness in Internal Control over Compliance and Material Noncompliance Criteria ‐ 2 CFR 200.33(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statues, regulations, and conditions of the federal award. The Medical Center is required to submit an accurate report to HHS for the filing period that funds were received. Condition ‐ The Medical Center claimed lost revenues attributable to coronavirus in which the revenue calculation did not agree to the HHS special report for one key line item. Cause ‐ The Medical Center had a revenue calculation error of $192,326 on the HHS special report with no impact to the actual lost revenues as the quarter with the error did not result in any lost revenue being reported (i.e., lost revenue claimed was accurate on the HHS special report but key line items were misstated). Effect ‐ While the calculation error did not provide a difference in total between the lost revenues utilized on the HHS special report and the lost revenue calculation, the Medical Center’s reported quarterly resident revenues were inaccurate. This calculation error also indicated a lack of proper reconciliation between the Medical Center’s audited financial statements and the revenues reported within the HHS special report. Questioned Costs ‐ None reported. Context ‐ There were 40 lost revenue key line items tested on which one key line item contained an error which totaled $192,326 (explicit price concessions were overstated for one quarter). The error had no impact on the amount of lost revenue as the quarter impacted did not result in any lost revenue. Repeat Finding from Prior Years – No Recommendation ‐ We recommend that the Medical Center enhance internal control policies to ensure the HHS special report is supported by accurate revenue calculations. This would include reconciling the lost revenue calculation to the audited financial statements within the secondary review of the HHS special report. Views of Responsible Officials ‐ Management agrees with the finding.

Corrective Action Plan

Finding 2023-002 Federal Agency Name: Department of Health and Human Services Program Name: COVID-19 Provider Relief Fund (PRF) and American Rescue Plan (ARP) Rural Distribution CFDA #93.498 Finding Summary: The Medical Center had a revenue calculation error of $192,326 on the HHS special report with no impact to the actual lost revenues as the quarter with the error did not result in any lost revenue being reported (i.e., lost revenue claimed was accurate on the HHS special report but key line items were misstated). Responsible Individuals: Cathy Huss, CFO Corrective Action Plan: All tracking documents that have calculations will be reviewed by the CEO if the CFO compiles for accuracy and vice versa. The reviewer will sign off by email that they have reviewed and agree with the calculations. The calculation of lost revenues will be updated with our next reporting to HHS. Anticipated Completion Date: 6/30/2023

About Reporting →

FY 2021-09-30

$5,431,926 federal awards expended

FAC accepted this audit on June 29, 2022 — management decision was due December 29, 2022.

2021-002
Other
MATERIAL WEAKNESS

The Medical Center does not have an internal control system designed to provide for a complete and accurate consolidated schedule of expenditures of federal awards being audited. We were requested to draft the Schedule. Cause: Auditor assistance with preparation of the Schedule is not unusual, as the Schedule has unique and specialized requirements and preparation is only required when the Medical Center meets a specified threshold of federal expenditures. Effect: There is a reasonable possibility that the Medical Center would not be able to draft a Schedule that is correct without assistance of the auditors. Questioned Costs: None reported. Context: Sampling was not used. Repeat Finding from Prior Years: No Recommendation: We recommend that be aware of the financial reporting requirements relating to the Medical Center?s schedule of expenditures of federal awards and internal controls that impact financial reporting. Views of Responsible Officials: Management agrees with the finding.

Show full finding ▾
Full finding narrative

2021-002 Department of Health and Human Services Federal Assistance Listing/CFDA #93.498 COVID-19 Provider Relief Fund and American Rescue Plan Rural Distribution Applicable Federal Award Number and Year- Period 1 TIN #411804205 Preparation of the Schedule of Expenditures of Federal Awards Material Weakness in Internal Control Over Compliance - Other Criteria: Proper controls over financial reporting include the ability to prepare the schedule of expenditures of federal awards (Schedule) and accompanying notes to the Schedule. Condition: The Medical Center does not have an internal control system designed to provide for a complete and accurate consolidated schedule of expenditures of federal awards being audited. We were requested to draft the Schedule. Cause: Auditor assistance with preparation of the Schedule is not unusual, as the Schedule has unique and specialized requirements and preparation is only required when the Medical Center meets a specified threshold of federal expenditures. Effect: There is a reasonable possibility that the Medical Center would not be able to draft a Schedule that is correct without assistance of the auditors. Questioned Costs: None reported. Context: Sampling was not used. Repeat Finding from Prior Years: No Recommendation: We recommend that be aware of the financial reporting requirements relating to the Medical Center?s schedule of expenditures of federal awards and internal controls that impact financial reporting. Views of Responsible Officials: Management agrees with the finding.

Corrective Action Plan

Finding 2021-002 Federal Agency Name: Department of Health and Human Services Program Name: COVID-19 Provider Relief Fund and American Rescue Plan Rural Distribution CFDA #93.498 Finding Summary: Eide Bailly assisted in the preparation of our draft schedule of expenditures and federal awards and accompanying notes to the consolidated schedule of expenditures of federal awards. Responsible Individuals: Cathy Huss, CFO Corrective Action Plan: It is not cost effective to have an internal control system designed to provide for a complete and accurate schedule of expenditures of federal awards. We requested that our auditors, Eide Bailly LLP, assist in the preparation of the schedule of expenditures. We have designated a member of management to review the drafted schedule of federal expenditures. Anticipated Completion Date: Ongoing.

About Other →
2021-003
Activities Allowed or Unallowed / Cost Allowability
SIGNIFICANT DEFICIENCY

Three executives were identified that may have exceeded the Executive Level II limitations if assessed based on the rate of pay being annualized. Cause: The Medical Center did not consider the Executive Level II salary limit when reporting salaries under the federal program. Effect: Without consideration of Executive Level II salary limit, there is a possibility that ineligible expenditures may be reported under the program. Questioned Costs: None reported. The salary in excess of the Executive Level II limit for the identified executive that may have exceeded the Executive Level II limitation, if assessed based on the rate of pay being annualized, was less than $25,000. Context: Detail testing was performed over Incident Command payroll expenses. Of the nine employees that made up Incident Command, three employees were over the executive compensation level. Repeat Finding from Prior Years: No Recommendation: We recommend the Medical Center document the consideration of the Executive Level II salary limit interpretation when reporting salaries under the federal program. Views of Responsible Officials: Management agrees with the finding.

Show full finding ▾
Full finding narrative

2021-003 Department of Health and Human Services Federal Assistance Listing/CFDA #93.498 COVID-19 Provider Relief Fund and American Rescue Plan Rural Distribution Applicable Federal Award Number and Year ? Period 1 TIN #411804205 Activities Allowed or Unallowed and Allowable Cost/Cost Principles Significant Deficiency in Internal Control Over Compliance Criteria: 2 CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award. The federal award?s Terms and Conditions Section 202 Executive Pay states none of the funds appropriated under this federal program shall be used to pay the salary of an individual, through a grant or other mechanism, at a rate in excess of Executive Level II of the Federal Executive PayScale determined to be $197,300 effective January 2020 and $199,300 effective January 2021. The interpretation of the Executive Level II limitations is subjective as to whether the rate of pay is to be assessed solely on an annual basis or if it is assessed based on the rate of pay, if annualized, does not exceed an annual amount based on full-time equivalent basis. Condition: Three executives were identified that may have exceeded the Executive Level II limitations if assessed based on the rate of pay being annualized. Cause: The Medical Center did not consider the Executive Level II salary limit when reporting salaries under the federal program. Effect: Without consideration of Executive Level II salary limit, there is a possibility that ineligible expenditures may be reported under the program. Questioned Costs: None reported. The salary in excess of the Executive Level II limit for the identified executive that may have exceeded the Executive Level II limitation, if assessed based on the rate of pay being annualized, was less than $25,000. Context: Detail testing was performed over Incident Command payroll expenses. Of the nine employees that made up Incident Command, three employees were over the executive compensation level. Repeat Finding from Prior Years: No Recommendation: We recommend the Medical Center document the consideration of the Executive Level II salary limit interpretation when reporting salaries under the federal program. Views of Responsible Officials: Management agrees with the finding.

Corrective Action Plan

Finding 2021-003 Federal Agency Name: Department of Health and Human Services Program Name: COVID-19 Provider Relief Fund and American Rescue Plan Rural Distribution CFDA #93.498 Finding Summary: Executive Level II limitations were exceeded when reporting costs for three executive level employees based on guidance under the federal award's Terms and Conditions Section 202 Executive Pay Responsible Individuals: Cathy Huss, CFO Corrective Action Plan: Management will monitor Executive Level II limitations and assess the rate of pay for executives on a rate by hour basis, as well as on an annual basis. Management will also continue to monitor the executive level pay. Anticipated Completion Date: 6/30/2022

About Activities Allowed or Unallowed, Allowable Costs / Cost Principles →
2021-004
Activities Allowed or Unallowed / Cost Allowability
MATERIAL WEAKNESS

There was no formal documentation of review and approval of the listing of eligible expenditures claimed under the program. There was also no formal review over tracking of other sources of funding to ensure that expenses claimed for the program were not claimed by other funding sources. The Medical Center?s calculation of lost revenue claimed under the federal program as an allowable cost contained no formal review or approval by a separate individual outside of the preparer. Cause: The Medical Center did not have an adequate internal control policy in place to ensure review and approval of direct and incremental COVID expenses, tracking of other funding sources, or calculation of lost revenue. Effect: The lack of adequate policies governing review and approval increases the risk that employees participating in the federal award administration may not be able to detect and correct noncompliance in a timely manner. Questioned Costs: None reported. Context/Sampling: Detail testing was performed over eligible expenditures for activities allowed and unallowable and allowable cost/cost principles. In addition, the lost revenue calculation for all applicable quarters was tested. Repeat Finding from Prior Years: No Recommendation: We recommend that the Medical Center enhance internal control policies to ensure that formal documentation of review and approval is present. Views of Responsible Officials: Management agrees with the finding.

Show full finding ▾
Full finding narrative

2021-004 Department of Health and Human Services Federal Assistance Listing/CFDA #93.498 COVID-19 Provider Relief Fund and American Rescue Plan Rural Distribution Applicable Federal Award Number and Year ? Period 1 TIN #411804205 Activities Allowed or Unallowed and Allowable Cost/Cost Principles Material Weakness in Internal Control Over Compliance Criteria: 2 CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award. Condition: There was no formal documentation of review and approval of the listing of eligible expenditures claimed under the program. There was also no formal review over tracking of other sources of funding to ensure that expenses claimed for the program were not claimed by other funding sources. The Medical Center?s calculation of lost revenue claimed under the federal program as an allowable cost contained no formal review or approval by a separate individual outside of the preparer. Cause: The Medical Center did not have an adequate internal control policy in place to ensure review and approval of direct and incremental COVID expenses, tracking of other funding sources, or calculation of lost revenue. Effect: The lack of adequate policies governing review and approval increases the risk that employees participating in the federal award administration may not be able to detect and correct noncompliance in a timely manner. Questioned Costs: None reported. Context/Sampling: Detail testing was performed over eligible expenditures for activities allowed and unallowable and allowable cost/cost principles. In addition, the lost revenue calculation for all applicable quarters was tested. Repeat Finding from Prior Years: No Recommendation: We recommend that the Medical Center enhance internal control policies to ensure that formal documentation of review and approval is present. Views of Responsible Officials: Management agrees with the finding.

Corrective Action Plan

Finding 2014-004 Federal Agency Name: Department of Health and Human Services Program Name: COVID-19 Provider Relief Fund and American Rescue Plan Rural Distribution CFDA #93.498 Finding Summary: There was no formal documentation of review and approval for overall expenses claimed or the calculation of lost revenue by a separate individual outside of the preparer. Responsible Individuals: Cathy Huss, CFO Corrective Action Plans: All tracking documents that have calculations will be reviewed by the CEO if the CFO compiles for accuracy and vice versa. The reviewer will sign off by email of by physical signature that they have reviewed and agree with the calculations. Anticipated Completion Date: 6/30/2022

About Activities Allowed or Unallowed, Allowable Costs / Cost Principles →

Data source: This information comes from the Federal Audit Clearinghouse, the official repository of Single Audit data. All data is public domain. Verify this organization's audit history at fac.gov.

Browse other Single Audit organizations in Minnesota

Are you this organization?

Track your findings and corrective action plans across audit cycles.

Start tracking findings →

Do you fund this organization?

Add it to a monitored group and get alerted when a new audit, finding, repeat finding, or management-decision deadline shows up — instead of checking back.

Checking several at once? Portfolio view →

Product

Resources

Legal

Single Audit Intelligence is an independent tool powered by Federal Audit Clearinghouse data. Not affiliated with GSA, OMB, or any federal agency.

© 2026 Single Audit Intelligence. All data is public domain.